Taipei, Taiwan

Ting-Yi Sung


Average Co-Inventor Count = 12.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):

Title: Innovations of Ting-Yi Sung in Cancer Treatment

Introduction

Ting-Yi Sung is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of cancer detection and treatment through his innovative research and development of antibodies.

Latest Patents

One of his key patents is the development of anti-EGF like domain multiple 6 (EGFL6) antibodies. This invention relates to the use of anti-EGFL6 antibodies for cancer detection and treatment. The patent focuses on creating anti-EGFL6 antibodies, particularly single-chain antibody fragments (scFv) and humanized antibodies. These antibodies have the ability to bind to EGFL6, inhibiting angiogenesis and cancer cell growth. Ting-Yi Sung holds 1 patent in this area.

Career Highlights

Throughout his career, Ting-Yi Sung has worked with prestigious institutions such as Taipei Medical University and Changhua Christian Medical Foundation Changhua Christian Hospital. His work has been instrumental in advancing cancer research and therapeutic strategies.

Collaborations

He has collaborated with notable colleagues, including Yu-Ching Lee and Shiow-Lin Pan, to further enhance the impact of his research in the medical field.

Conclusion

Ting-Yi Sung's innovative work in developing anti-EGFL6 antibodies represents a significant advancement in cancer treatment and diagnosis. His contributions continue to influence the field and offer hope for improved therapeutic options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…